Dr. Omer N. Koc, MD

Dr. Koc practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Koc's NPI, 1588629059, was assigned on April 19, 2006. Dr. Koc graduated from Istanbul University Fom in 1987. Dr. Koc holds Ohio license 35062252.

Dr. Koc's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Koc's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Koc is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Koc to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Koc's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koc practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Koc's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Koc is board certified in hematology by the American Board of Internal Medicine. Dr. Koc is licensed in Ohio.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Koc treats.

CMS data shows 1,623 Medicare services from Dr. Koc across 9 procedure codes in 2024, for 536 Medicare patients. Medicare paid $75,157 for them.

CMS counts 536 Medicare patients who saw Dr. Koc in 2024. The largest group is 75 to 84, with 244 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koc's median patient age at 71, with 63% women.

In 2024, Dr. Koc wrote 1,944 Medicare Part D claims for 323 patients. 63% of them were for generic drugs. CMS names the drug for 1,510 of them, across 39 drugs with 11 or more claims each, at $7,777,245 in total drug cost. In 2023, CMS named 1,374 claims across 41 drugs.

Dr. Koc accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koc as offering telehealth.

Dmand AI links 25 papers to Dr. Koc, published from 2007 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation, Antineoplastic Combined Chemotherapy Protocols and Histocompatibility Testing. Dr. Koc has published most often in Biol Blood Marrow Transplant. Dr. Koc's most frequent co-authors are Paolo F. Caimi, MD, Brenda W. Cooper, MD and Robert M. Dean, MD.

Dmand AI links Dr. Koc to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell and Leukemia, Large Granular Lymphocytic. Case Comprehensive Cancer Center sponsors the most, 4.

CMS Open Payments shows 3 general payments to Dr. Koc from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 96% of the total. BeiGene, Ltd. paid the most, $139.

Dmand AI lists 1 award for Dr. Koc, most recently CMS Stage 1 EHR in 2013.

Dr. Koc graduated from Istanbul University Fom in 1987. Dr. Koc is a member of ASCO.

Dr. Koc is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.